# Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel

> **NCT02925923** · PHASE2 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 100 (actual)

## Conditions studied

- Acute Coronary Syndrome
- Angina, Unstable

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Eptifibatide
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT02925923
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-01
- **Primary completion:** 2018-01-30
- **Final completion:** 2018-12-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02925923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02925923, "Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02925923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*